Loading...

457 posters, 2 videos, 2 audios, 8 topics, 45 sessions, 401 authors, 265 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting

March 21-23, 2024 | The Hilton Bayfront San Diego | San Diego, California

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting banner

5184

MULTIPLE SINGLE - INJECTION SPINALS FOR BROMELAIN ‐ BASED ENZYMATIC BURN DEBRIDEMENT

Part of Topic

Medically Challenging Cases

Multiple Single-Injection Spinals for Bromelain Based Enzymatic Burn Debridement

Christina Zecca, M.D., Nicolas Salvatierra, M.D., Meaghan Kenfield, M.D., Justin Chung, M.D., Tiffany Tedore, M.D

Department of Anesthesiology, NewYork-Presbyterian/Weill Cornell Medicine, New York, NY


Introduction:


  • Bromelain-based enzymatic debridement is a novel method for debridement of deep dermal / full thickness burns derived from pineapple plant stem extract 1

  • Pain management during treatment can be a challenge secondary to the severity of pain and length of the procedures 2,3

  • A consideration for regional anesthesia is the percentage of total body surface area (TBSA) burned and location of the burn 2,3

  • Catheters should not be placed through burned skin or eschar, but single-injection spinal anesthesia and nerve blocks can safely be performed through burned skin 2,3

  • In cases where neuraxial is utilized and a catheter is contraindicated, the duration of sensory blockade may not be sufficient for the entirety of the procedure 2,3

  • Repeated spinal anesthesia, which has been performed safely in other patient populations, can be considered 4

Case Description

  • A 24-year-old male with no significant past medical history presented with 21.5% TBSA scald burn to the back and bilateral lower extremities, scheduled for bromelain-based debridement of his lower extremities in the ICU

  • The patient had a second degree burn overlying the lumbar spine (figure 1), precluding the placement of combined spinal-epidural (CSE)

  • Single-injection spinal anesthesia was administered using 13 mg of isobaric bupivacaine 0.5% and 200 mcg of epinephrine at the L4-L5 interspace

  • The patient tolerated the initial part of the procedure; however, during the debridement period, the patient experienced decreased motor and sensory blockade

  • After careful neuromotor examination, the decision was made to administer a second dose of spinal anesthesia approximately 6 hours later, with 11 mg of isobaric bupivacaine 0.5% and 100 mcg of epinephrine

  • The patient tolerated repeat spinal anesthesia without complications and was pain-free for the remaining duration of the procedure


Discussion

  • Regional anesthesia is optimal for bromelain-based debridement to be performed bedside 3

  • Due to the length of the procedure, epidural catheters and peripheral nerve catheters are preferred, but overlying burned skin or eschar pose a challenge

  • Few studies have evaluated the safety of multiple spinal anesthetics 4,5; with repeated intrathecal administration of local anesthetic, there is concern for high spinal, bradycardia, hypotension, and neurological sequelae. 

  • This case highlights the safety and efficacy of repeated spinal anesthesia for bromelain-based enzymatic debridement 

  • There were no complications from the repeated spinal anesthetics in this case, and this remains a viable option not only in bromelain-based enzymatic debridement, but for patients undergoing similar procedures with a contraindication to catheter placement

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.